Survey Shows Women with PCOS Not Happy with Their Medical Care

A U.S.-based survey of women with polycystic ovary syndrome (PCOS), a common condition characterized by reproductive and metabolic problems, points to distrust and lack of social support from healthcare providers as major contributing factors in their negative medical care experiences, according to a new study published in the Endocrine Society’s Journal of the Endocrine Society.

An estimated 5 million to 6 million women in the U.S. suffer from PCOS, but many have yet to be diagnosed. PCOS affects 7% to 10% of women of reproductive age, making it the most common cause of infertility. The disorder can cause distressing symptoms like irregular periods, weight gain, many small ovarian cysts, and excess hair, and it’s been linked to other health conditions like mental health disorders, type 2 diabetes, obesity, and heart disease.

“This research provides new and important evidence pertaining to deficiencies in trust and social support from healthcare providers that may contribute to negative medical experiences for patients with PCOS,” says Marla E. Lujan, PhD, of Cornell University in Ithaca, N.Y. “Our study suggests that physicians can improve the patient-provider relationship by tailoring their advice to acknowledge the broad impact that PCOS has on women’s lives, and to listen to patient concerns without judgement. These efforts can potentially bring about continuity of care for women with PCOS.”

“This research provides new and important evidence pertaining to deficiencies in trust and social support from healthcare providers that may contribute to negative medical experiences for patients with PCOS.” – Marla E. Lujan, PhD, Cornell University, Ithaca, N.Y.


This cross-sectional study included 332 U.S.-based women — 134 with and 198 without PCOS. The study found that women with PCOS believe primary care physicians are well qualified to treat general health concerns but trust their opinions less when addressing issues related to PCOS. This may be because of the limited information these women receive from healthcare professionals about the disorder and the significant lag time between PCOS symptom onset and diagnosis. A survey published in The Journal of Clinical Endocrinology & Metabolism in December 2016 found many women with PCOS consulted three or more healthcare providers and waited at least two years for a diagnosis.

In the new survey, women who had PCOS also reported arguments with their physicians and an overall lack of emotional support and empathy. It’s especially important to provide the right information about emotional counseling to these patients as they often suffer from anxiety and depression, which are associated with PCOS.

“PCOS is a complex medical condition that requires lifelong care,” said co-investigator, Annie W. Lin, PhD, RD, of Cornell University. “Improving the patient-provider relationship is an important first step to ensuring a successful long-term partnership focused on providing patients with timely and appropriate care.”

Other authors of the study include: Elena J. Bergomi, Jamie S. Dollahite, and Jeffery Sobal of Cornell University; and Kathleen M. Hoeger of University of Rochester Medical Center in Rochester, N.Y.

The study received support from the Cornell University Human Ecology Alumni Association and College of Agriculture and Life Sciences Alumni Association.

The study, “Trust in Physicians and Medical Experience Beliefs Differ between Women with and without Polycystic Ovary Syndrome,” will be published online.

You may also like

  • New Perspectives on PCOS

    As the incidence of polycystic ovary syndrome grows, so does an increased awareness. Statistics show that nearly 10% of women have polycystic ovary syndrome (PCOS), making it one of the leading causes of infertility, and new research indicates that it seems to be on the rise. Three recent studies from The Journal of Clinical Endocrinology…

  • Shouldering Responsibility: Could a Male Contraceptive Gel Be a Birth Control Game Changer?

    When a presentation at ENDO 2024 highlighted a male contraceptive gel that suppresses sperm production faster than other hormone-focused methods of male birth control, the Boston Convention Center was abuzz. Containing segesterone acetate and testosterone and applied to both shoulders, this groundbreaking new birth control could prove revolutionary. When the results from an ongoing multicenter…

Find more in